These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38042824)

  • 21. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
    Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
    Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review.
    Zhang L; Wang G; Hou W; Li P; Dulin A; Bonkovsky HL
    Hepatology; 2010 Feb; 51(2):690-8. PubMed ID: 20101751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy.
    Tavakolpour S; Mirsafaei HS; Elkaei Behjati S; Ghasemiadl M; Akhlaghdoust M; Sali S
    Immunol Lett; 2017 Oct; 190():206-212. PubMed ID: 28827021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B.
    Lei J; Wang Y; Wang LL; Zhang SJ; Chen W; Bai ZG; Xu LY
    Virol J; 2013 Oct; 10():313. PubMed ID: 24160943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tenofovir disoproxil fumarate for multiple nucleos(t)ide analogues treatment failure hepatitis B: Is monotherapy enough?
    Liang X; Xie Q; Shang J; Tang H; Xu M; Meng Q; Zhang J; Gao P; Sheng J; Wang H; Jia J; Wang G; Wu S; Ping J; Hou J
    J Gastroenterol Hepatol; 2022 Mar; 37(3):471-479. PubMed ID: 34894002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino acid polymorphism in the reverse transcriptase region of hepatitis B virus and the relationship with nucleos(t)ide analogues treatment for preventing mother-to-infant transmission.
    Chen J; Yan L; Zhu FC; Liu JX; Li RC; Wang FZ; Li J; Zhuang H
    J Med Virol; 2014 Aug; 86(8):1288-95. PubMed ID: 24777553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Albumin-bilirubin score is associated with response to pegylated interferon and nucleos(t)ide analogues in chronic hepatitis B patients.
    Xun Z; Liu C; Yu QQ; Lin JP; Huang JL; Yang TW; Wu WN; Wu SH; Ou QS
    Clin Chim Acta; 2020 Mar; 502():120-127. PubMed ID: 31891671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A possible mechanism for low-level viremia occurrence in nucleos(t)ide analog-treated chronic hepatitis B patients].
    Wang LJ; Gu ZQ; Xu ZM; Chen XM; Lu FM
    Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1151-1155. PubMed ID: 35045629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum HBV DNA plus RNA reflecting cccDNA level before and during NAs treatment in HBeAg positive CHB patients.
    Wang Y; Liu Y; Liao H; Deng Z; Bian D; Ren Y; Yu G; Jiang Y; Bai L; Liu S; Liu M; Zhou L; Chen Y; Chen X; Duan Z; Lu F; Zheng S
    Int J Med Sci; 2022; 19(5):858-866. PubMed ID: 35693741
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection.
    Burdette D; Hyrina A; Song Z; Beran RK; Cheung T; Gilmore S; Kobayashi T; Li L; Liu Y; Niedziela-Majka A; Medley J; Mehra U; Morganelli P; Novikov N; Niu C; Tam D; Tang J; Wang J; Yue Q; Fletcher SP; Holdorf MM; Delaney WE; Feierbach B; Lazerwith S
    Antimicrob Agents Chemother; 2023 Jan; 67(1):e0134822. PubMed ID: 36519892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B functional cure and immune response.
    Zheng JR; Wang ZL; Feng B
    Front Immunol; 2022; 13():1075916. PubMed ID: 36466821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?
    Kao JH
    Liver Int; 2014 Feb; 34 Suppl 1():112-9. PubMed ID: 24373087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.
    Wong DK; Seto WK; Fung J; Ip P; Huang FY; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1004-10.e1. PubMed ID: 23376799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA.
    Liu YY; Liang XS
    World J Hepatol; 2018 Sep; 10(9):603-611. PubMed ID: 30310538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can we cure hepatitis B virus with novel direct-acting antivirals?
    Martinez MG; Villeret F; Testoni B; Zoulim F
    Liver Int; 2020 Feb; 40 Suppl 1():27-34. PubMed ID: 32077597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New paradigms in hepatitis B management: only diamonds are forever.
    Coffin CS; Lee SS
    Br Med Bull; 2015; 116():79-91. PubMed ID: 26377741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapy.
    Hui RW; Mak LY; Seto WK; Yuen MF; Fung J
    Expert Rev Gastroenterol Hepatol; 2023 May; 17(5):443-450. PubMed ID: 36972516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levels of HBV RNA in chronic HBV infected patients during first-line nucleos(t)ide analogues therapy.
    Jiang B; Dai Q; Liu Y; Yu G; Mi Y
    Infect Agent Cancer; 2022 Dec; 17(1):61. PubMed ID: 36476371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of mutations in HBV DNA polymerase gene associated with nucleos(t)ide resistance in treatment-naive patients with Chronic Hepatitis B in Central China.
    Zhao Y; Wu J; Sun L; Liu G; Li B; Zheng Y; Li X; Tao J
    Braz J Infect Dis; 2016; 20(2):173-8. PubMed ID: 26876337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.
    Rinker F; Zimmer CL; Höner Zu Siederdissen C; Manns MP; Kraft ARM; Wedemeyer H; Björkström NK; Cornberg M
    J Hepatol; 2018 Sep; 69(3):584-593. PubMed ID: 29758333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.